The beneficial effect of vitamin C supplementation on serum lipids in type 2 diabetic patients: A randomized double blind study

International Journal of Diabetes and Metabolism

Volumn 20, Issue 2, 2012, Pages 53-58

  Chaudhari, Harshal V ^a   Dakhale, Ganesh N ^a   Chaudhari, Shashikumar ^b   Kolhe, Swati ^c   Hiware, Sachin ^a   Mahatme, Mohini ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b Dr Panjabrao Deshmukh Polytechnic   (India)

^c All India Shree Shivaji Memorial Society's College of Pharmacy   (India)

Author keywords

Antioxidants; Ascorbic acid; Diabetes mellitus; Lipid profile; Oxidative stress; Vitamin C

Indexed keywords

ASCORBIC ACID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; METFORMIN; PLACEBO; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSLIPIDEMIA; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PARALLEL DESIGN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TERTIARY HEALTH CARE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 84869768748     PISSN: 16067754     EISSN: None     Source Type: Journal    
DOI: 10.1159/000497726     Document Type: Article

References (40)

1. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339:229-234.
2. Mooradian AD. Cardiovascular disease in type 2 diabetes mellitus: current management guidelines. Arch Intern Med 2003; 163:33-40.
3. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004; 164:1422-1426.
4. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000; 49:27-29.
5. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 1999; 48:1-9.
6. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40:405-412.
7. Krauss RM, Siri PW. Dyslipidemia in type 2 diabetes, Med Clin N Am 2004; 88:897-909.
8. Bisht S, Sisodia SS. Diabetes, Dyslipidemia, Antioxidant and status of oxidative stress, Int J Res Ayurveda & pharmacy 2010; 1:33-42.
9. Chahil TJ, Ginsberg HN. Diabetic dyslipidemia. Endocrinol Metab Clin North Am 2006; 35:491-510.
10. Fadupin GT, Akpoghor AU, Okunade KA. Comparative study of serum ascorbic acid level in people with and without type 2 diabetes in Ibadan, Nigeria. Afr J Med Sci. 2007; 36:335-339.
11. Afkhami-Ardekani M, Shojaoddiny-Ardekani A. Effect of vitamin C on blood glucose, serum lipids & serum insulin in type II diabetes patients. Indian J Med Res. 2007; 126:471-474.
12. Sharma P, Pramod J, Sharma PK, Chaturvedi SK, Kothari LK: Effect of vitamin C administration on serum and aortic lipid profile of guineapigs. Indian J Med Res 1988; 87:283-289.
13. Cerná O, Ginter E: Blood lipids and vitamin-C status. Lancet 1978; 1:1055-1056.
14. Greco AM, LaRocca L. Correlation between chronic hypovitaminosis C in old age and plasma levels of cholesterol and triglycerides. Int J Vit Nutr Res Suppl 1982; 23:129-136.
15. Knox EG. Ischemic-heart-disease mortality and dietary intake of calcium. Lancet 1973; 1:1465-1467.
16. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992; 3:194-202.
17. Gale CR, Martyn CN, Winter PD, Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. Br Med J 1995; 310:1563-1566.
18. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary disease in men. N Engl J Med 1993; 328:1450-1456.
19. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328:1444-1449.
20. Sridulyakul P, Chakraphan D, Patumraj S. Vitamin C supplementation could reverse diabetes-induced endothelial cell dysfunction in mesenteric microcirculation in STZ-rats. Clin Hemorheol Microcirc 2006; 34:315-21.
21. Ardekani MA, Mohiti J, Amirchaghmaghi E, Modarresi M. The effect of vitamin C supplementation on insulin level, HbA1c and blood glucose in type 2 diabetic patients. J Beh Kerm Univ Med Sci. 2006; 11:12-18.
22. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J. Consequences of the diabetic status on the oxidant/ antioxidant balance. Diabetes Metab 2000; 26:163-176.
23. Ceriello A, Bortolotti N, Crescentini A, Motz E, Lizzio S, Russo A, Ezsol Z, Tonutti L, Taboga C. Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. Eur J Clin Invest 1998; 28:329-333.
24. Hirsch IB, Atchley DH, Tsai E, Labbé RF, Chait A. Ascorbic acid clearance in diabetic nephropathy. J Diabetes Complications. 1998; 12:259-263.
25. Vincent TE, Mendiratta S, May JM. Inhibition of aldose reductase in human erythrocytes by vitamin C. Diabetes Res Clin Pract 1999; 43:1-8.
26. Watts GF. Coronary disease, dyslipidemia and clinical trials in type 2 diabetes mellitus. Pract Diab Int 2000; 17:54-59.
27. Suryawanshi NP, Bhutey AK, Nagdeote AN, Jadhav AA, Manoorkar GS. Study of lipid peroxide and lipid profile in diabetes mellitus. Indian J Clin Biochem 2006; 21:126-130.
28. UK Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes care 1997; 20:1683-1687.
29. Agboola-Abu CF, Ohwovoriole A, Akinlade KS. The effect of glycemic control on the prevalence and patterns of dyslipidaemia in Nigerian patients with newly diagnosed non-insulin dependent diabetes mellitus. West Afr J Med 2000; 19:27-33.
30. Paolisso G, Balbi V, Volpe C, Varricchio G, Gambardella A, Saccomanno F, Ammendola S, Varricchio M, D'Onofrio F. Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics. J Am Coll Nutr 1995; 14:387-392.
31. Bishop N, Schorah CJ, Wales JK. The effect of vitamin C supplementation on diabetic hyperlipidaemia: a double blind, crossover study. Diabet Med 1985; 2:121-124.
32. Tofler GH, Stec JJ, Stubbe I, Beadle J, Feng D, Lipinska I, Taylor A. The effect of vitamin C supplement on coagulability and lipid levels in healthy male subjects. Thrombosis Res 2000; 100:35-41.
33. Gale CR, Martyn CN, Winter PD, Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. Br Med J 1995; 310:1563-1566.
34. Sahyoun NR, Jacques PF, Russel RM. Carotenoids, vitamin C and E and mortality in an elderly population. Am J Epidemiol 1996; 144:501-511.
35. Oguntibeju OO, Fafunso MA. Serum ascorbate, cholesterol and totatl protein levels in newly diagnosed non-insulin dependent diabetes mellitus (NIDDM) among Nigerians. Med Tech SA 2002; 16: 358-360.
36. Frei B, Stocker R, England L, Ames BN. Ascorbate: the most effective antioxidant in human blood plasma. Adv Exp Med Biol 1990; 264:155-163.
37. Bjorkhem I, Kallner A. Hepatic 7a-hydroxylation of cholesterol in ascorbate-deficient and ascorbate-supplemented guinea pigs. J Lipid Res 1976; 17:360-365.
38. Peterson FJ, Holloway DE, Duquette PH, Rivers JM. Dietary ascorbic acid and hepatic mixed function oxidase activity in the guinea pig. Biochem Pharmacol 1983; 32:91-96.
39. Mullan BA, Young IS, Fee H, McCance DR. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 2002; 40:804-809.
40. Eckel RH. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 1989; 320:1060-1068.